Literature DB >> 7723240

New mouse model for polycystic kidney disease with both recessive and dominant gene effects.

L Flaherty1, E C Bryda, D Collins, U Rudofsky, J C Montogomery.   

Abstract

In the course of studying the genetics of chlorambucil mutagenesis, we have uncovered a new model for autosomal polycystic kidney disease (PKD). In the homozygous condition, the gene, jcpk, causes a very severe disease characterized by cysts in all segments of the nephron. Death usually occurs before 10 days of age. Extrarenal involvement was also noted; enlarged bile ducts, pancreatic ducts, and gall bladder often accompanied the PKD. In addition, approximately 25% of the aged +/jcpk heterozygotes show evidence of glomerulocystic disease. This gene maps to Chromosome 10 between two DNA markers, D10Mit20 and D10Mit42. Because this gene causes extrarenal abnormalities and because it has a heterozygote effect, it may be an informative animal model for the commonly occurring human adult dominant PKD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723240     DOI: 10.1038/ki.1995.69

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.

Authors:  Zakir Hossain; Safiah Mohamed Ali; Hui Ling Ko; Jianliang Xu; Chee Peng Ng; Ke Guo; Zeng Qi; Sathivel Ponniah; Wanjin Hong; Walter Hunziker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

2.  The SAM domain of ANKS6 has different interacting partners and mutations can induce different cystic phenotypes.

Authors:  Zeineb Bakey; Marie-Thérèse Bihoreau; Rémi Piedagnel; Laure Delestré; Catherine Arnould; Alexandre d'Hotman de Villiers; Olivier Devuyst; Sigrid Hoffmann; Pierre Ronco; Dominique Gauguier; Brigitte Lelongt
Journal:  Kidney Int       Date:  2015-06-03       Impact factor: 10.612

3.  A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.

Authors:  R Pey; J Bach; G Schieren; N Gretz; M Hafner
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

4.  Differential rescue of the renal and hepatic disease in an autosomal recessive polycystic kidney disease mouse mutant. A new model to study the liver lesion.

Authors:  B K Yoder; W G Richards; C Sommardahl; W E Sweeney; E J Michaud; J E Wilkinson; E D Avner; R P Woychik
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity.

Authors:  Uyen Tran; Lise Zakin; Axel Schweickert; Raman Agrawal; Remziye Döger; Martin Blum; E M De Robertis; Oliver Wessely
Journal:  Development       Date:  2010-04       Impact factor: 6.868

6.  Loss of Bicc1 impairs tubulomorphogenesis of cultured IMCD cells by disrupting E-cadherin-based cell-cell adhesion.

Authors:  Yulong Fu; Ingyu Kim; Peiwen Lian; Ao Li; Liang Zhou; Cunxi Li; Dan Liang; Robert J Coffey; Jie Ma; Ping Zhao; Qimin Zhan; Guanqing Wu
Journal:  Eur J Cell Biol       Date:  2010-03-09       Impact factor: 4.492

7.  Bicc1 is a genetic determinant of osteoblastogenesis and bone mineral density.

Authors:  Larry D Mesner; Brianne Ray; Yi-Hsiang Hsu; Ani Manichaikul; Eric Lum; Elizabeth C Bryda; Stephen S Rich; Clifford J Rosen; Michael H Criqui; Matthew Allison; Matthew J Budoff; Thomas L Clemens; Charles R Farber
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

Review 8.  Translational research in ADPKD: lessons from animal models.

Authors:  Hester Happé; Dorien J M Peters
Journal:  Nat Rev Nephrol       Date:  2014-08-19       Impact factor: 28.314

9.  Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1.

Authors:  Anna-Rachel Gallagher; Ernie L Esquivel; Tiffany S Briere; Xin Tian; Michihiro Mitobe; Luis F Menezes; Glen S Markowitz; Dhanpat Jain; Luiz F Onuchic; Stefan Somlo
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

10.  TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex.

Authors:  Yu Tian; Robert Kolb; Jeong-Ho Hong; John Carroll; Dawei Li; John You; Roderick Bronson; Michael B Yaffe; Jing Zhou; Thomas Benjamin
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.